Method for constructing nucleic acid single-stranded cyclic library and reagents thereof

US10351848B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10351848-B2
Application numberUS-201415510882-A
CountryUS
Kind codeB2
Filing dateNov 26, 2014
Priority dateSep 12, 2014
Publication dateJul 16, 2019
Grant dateJul 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a method for constructing a nucleic acid single-stranded cyclic library and the reagents used therein. By the combination of interruption via a transposase with a restricted nick translation reaction, the method realizes a simple and rapid nucleic acid single-stranded cyclic library construction.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for constructing a library containing single-stranded cyclic nucleic acids, comprising: randomly fragmenting a double-stranded nucleic acid sample with a transposase embedded complex, which comprises transposase and a first adaptor containing a transposase recognition sequence, to obtain fragmented double-stranded nucleic acids ligated with the first adaptor at each terminal thereof, with a gap between each 3′-end and the first adaptor; ligating with a ligase a second adaptor to the fragmented double-stranded nucleic acid at the gap after removing the transposase from the reaction system, the second adaptor having a sequence different from that of the first adaptor; performing a first PCR reaction with a first primer containing a uracil to obtain a first PCR product ligated with a first adaptor sequence and a second adaptor sequence respectively at two ends thereof; enzyme-digesting the first PCR product with User enzyme at the uracil site to generate a gap, followed by double-stranded cyclization resulting in double-stranded cyclic nucleic acids; subjecting the double-stranded cyclic nucleic acid, as a template, to constrained nick translation from the gap; removing a portion without occurring the constrained nick translation in the double-stranded cyclic nucleic acids by digestion to obtain double-stranded linear nucleic acids; ligating a third adaptor and an oligonucleotide adaptor sequence to the 3′-end and the 5′-end of each strand of the double-stranded linear nucleic acid, respectively; performing a second PCR reaction with a second primer containing a first affinity marker at the 5′-end thereof, to obtain a second PCR product ligated with a third adaptor sequence and the oligonucleotide adaptor sequence respectively at two ends thereof; capturing the second PCR product with a carrier having a second affinity marker capable of combining with the first affinity marker, and isolating single-stranded nucleic acids without the first affinity marker through nucleic acid denaturation; and cyclizing the single-stranded nucleic acids without the first affinity marker with a single-stranded cyclization “bridge” sequence which is capable of combining with two ends of each single-stranded nucleic acid. 2. The method according to claim 1 , further comprising: digesting uncyclized single-stranded nucleic acids subsequent to cyclizing the single-stranded nucleic acids with the single-stranded cyclization “bridge” sequence. 3. The method according to claim 1 , wherein the transposase is removed from the reaction system by magnetic beads purification, column purification or chemical reagent treatment. 4. The method according to claim 1 , wherein a length of fragment generated during the constrained nick translation is controlled by an amount of dNTPs in the reaction system. 5. The method according to claim 1 , further comprising digesting uncyclized first PCR product prior to the constrained nick translation. 6. The method according to claim 1 , wherein removing a portion without occurring the constrained nick translation in the double-stranded cyclic nucleic acids by digestion further comprises: digesting the double-stranded cyclic nucleic acids with a double-stranded exonuclease until a first gap between two ends of the internal strand encounters a second gap between two ends of the external strand within one double-stranded cyclic nucleic acid; followed by digesting a portion without occurring the constrained nick translation in each strand of thus obtained double-stranded cyclic nucleic acids with a single-stranded exonuclease. 7. The method according to claim 1 , further comprising: end-repairing the double-stranded linear nucleic acid and dephosphorylating the 5′-end of each strand of the double-stranded linear nucleic acid prior to ligating the third adaptor to the 3′-end of each strand of the double-stranded linear nucleic acid. 8. The method according to claim 7 , comprising: subjecting the dephosphorylated 5′-end of each strand of the double-stranded linear nucleic acid to phosphorylation subsequent to ligating the third adaptor to the 3′-end of each strand of the double-stranded linear nucleic acid; and ligating the oligonucleotide adaptor sequence to the phosphorylated 5′-end of each strand of the double-stranded linear nucleic acid. 9. The method according to claim 1 , wherein the oligonucleotide adaptor sequence has a portion complementary with the third adaptor, wherein the portion is adjacent to the double-stranded linear nucleic acid. 10. The method according to claim 1 , wherein the first affinity marker is a biotin marker, and the second affinity marker is a streptavidin marker.

Assignees

Inventors

Classifications

  • General methods of preparing gene libraries, not provided for in other subgroups · CPC title

  • incorporating an adaptor · CPC title

  • Design, preparation, screening or analysis of libraries using computer algorithms · CPC title

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • using modified primers or templates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10351848B2 cover?
Provided are a method for constructing a nucleic acid single-stranded cyclic library and the reagents used therein. By the combination of interruption via a transposase with a restricted nick translation reaction, the method realizes a simple and rapid nucleic acid single-stranded cyclic library construction.
Who is the assignee on this patent?
Mgi Tech Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12N15/1093. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).